Free Trial

Sotera Health (SHC) Competitors

Sotera Health logo
$12.16 -0.10 (-0.82%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$12.16 -0.01 (-0.04%)
As of 05/23/2025 05:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SHC vs. HIMS, OPCH, GH, RDNT, BTSG, PRVA, SGRY, CON, VCYT, and LFST

Should you be buying Sotera Health stock or one of its competitors? The main competitors of Sotera Health include Hims & Hers Health (HIMS), Option Care Health (OPCH), Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Privia Health Group (PRVA), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Veracyte (VCYT), and LifeStance Health Group (LFST). These companies are all part of the "healthcare" industry.

Sotera Health vs.

Sotera Health (NASDAQ:SHC) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, community ranking, institutional ownership, media sentiment, analyst recommendations, dividends, earnings and profitability.

Sotera Health has a beta of 1.88, suggesting that its stock price is 88% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 1.84, suggesting that its stock price is 84% more volatile than the S&P 500.

In the previous week, Hims & Hers Health had 36 more articles in the media than Sotera Health. MarketBeat recorded 39 mentions for Hims & Hers Health and 3 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.71 beat Hims & Hers Health's score of 0.72 indicating that Sotera Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sotera Health
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Hims & Hers Health
21 Very Positive mention(s)
3 Positive mention(s)
9 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive

Sotera Health presently has a consensus price target of $15.80, suggesting a potential upside of 29.93%. Hims & Hers Health has a consensus price target of $37.67, suggesting a potential downside of 31.37%. Given Sotera Health's stronger consensus rating and higher probable upside, research analysts plainly believe Sotera Health is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sotera Health
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
Hims & Hers Health
2 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.08

Sotera Health received 8 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 58.89% of users gave Sotera Health an outperform vote while only 35.16% of users gave Hims & Hers Health an outperform vote.

CompanyUnderperformOutperform
Sotera HealthOutperform Votes
53
58.89%
Underperform Votes
37
41.11%
Hims & Hers HealthOutperform Votes
45
35.16%
Underperform Votes
83
64.84%

91.0% of Sotera Health shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 47.5% of Sotera Health shares are held by insiders. Comparatively, 13.7% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Sotera Health has higher earnings, but lower revenue than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sotera Health$1.11B3.12$51.38M$0.08152.00
Hims & Hers Health$1.78B6.89-$23.55M$0.6979.55

Hims & Hers Health has a net margin of 8.19% compared to Sotera Health's net margin of 6.31%. Sotera Health's return on equity of 42.27% beat Hims & Hers Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Sotera Health6.31% 42.27% 6.02%
Hims & Hers Health 8.19%10.97%8.29%

Summary

Sotera Health beats Hims & Hers Health on 11 of the 18 factors compared between the two stocks.

Get Sotera Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for SHC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SHC vs. The Competition

MetricSotera Healthhealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ Exchange
Market Cap$3.45B$2.01B$5.34B$8.30B
Dividend YieldN/A6.96%5.27%4.11%
P/E Ratio48.6415.7626.9619.59
Price / Sales3.123.70398.82136.02
Price / Cash10.279.3238.3234.64
Price / Book7.753.926.774.50
Net Income$51.38M$87.49M$3.24B$248.60M
7 Day Performance-5.00%0.14%0.27%-0.89%
1 Month Performance9.06%-2.64%5.91%7.41%
1 Year Performance8.57%-25.21%18.83%8.56%

Sotera Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SHC
Sotera Health
2.8313 of 5 stars
$12.16
-0.8%
$15.80
+29.9%
+8.6%$3.45B$1.11B48.643,000Positive News
HIMS
Hims & Hers Health
2.3345 of 5 stars
$62.35
-3.6%
$37.67
-39.6%
+225.4%$13.96B$1.78B141.71650Trending News
Analyst Upgrade
OPCH
Option Care Health
4.4368 of 5 stars
$33.09
-0.4%
$35.50
+7.3%
+8.2%$5.42B$5.19B27.815,600Positive News
GH
Guardant Health
4.6353 of 5 stars
$40.24
-1.1%
$52.32
+30.0%
+48.9%$4.99B$774.00M-11.301,790News Coverage
Positive News
RDNT
RadNet
3.3987 of 5 stars
$60.66
-0.8%
$69.75
+15.0%
-3.3%$4.55B$1.87B-866.458,970News Coverage
Analyst Downgrade
BTSG
BrightSpring Health Services
1.6107 of 5 stars
$24.11
-1.3%
$23.56
-2.3%
+105.2%$4.20B$11.86B-92.7335,000Positive News
PRVA
Privia Health Group
3.705 of 5 stars
$25.00
-0.1%
$27.38
+9.5%
+32.1%$3.05B$1.80B250.03810Positive News
SGRY
Surgery Partners
2.803 of 5 stars
$23.60
-1.4%
$34.75
+47.2%
-10.2%$3.02B$3.17B-49.1712,200Positive News
CON
Concentra Group Holdings Parent
N/A$22.54
-0.8%
$28.50
+26.4%
N/A$2.87B$1.93B16.8211,000Positive News
Ex-Dividend
VCYT
Veracyte
3.9483 of 5 stars
$29.00
-0.7%
$40.90
+41.0%
+30.6%$2.27B$463.39M-193.33790Positive News
LFST
LifeStance Health Group
2.4357 of 5 stars
$5.84
flat
$8.30
+42.1%
-3.7%$2.27B$1.28B-22.466,640Positive News

Related Companies and Tools


This page (NASDAQ:SHC) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners